Differential effects of intrastriatal and intranigral injections of glutamate antagonists on motor behaviour in the reserpine-treated rat. (Q48818709)

15 February 2018

title

Differential effects of intrastriatal and intranigral injections of glutamate antagonists on motor behaviour in the reserpine-treated rat. (English)

1 reference

15 February 2018

author name string

Kaur S

series ordinal

1 reference

15 February 2018

Starr MS

series ordinal

1 reference

15 February 2018

language of work or name

English

0 references

publication date

1 January 1997

1 reference

15 February 2018

published in

Neuroscience

1 reference

15 February 2018

volume

1 reference

15 February 2018

issue

1 reference

15 February 2018

page(s)

345-354

1 reference

15 February 2018

Feline subthalamic nucleus neurons contain glutamate-like but not GABA-like or glycine-like immunoreactivity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Excitatory amino acid binding sites in the basal ganglia of the rat: A quantitative autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

The functional anatomy of basal ganglia disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

The behavioral effects of MK-801 injected into nucleus accumbens and caudate-putamen of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Reversal of experimental parkinsonism by lesions of the subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Motor actions of eliprodil in the normal and monoamine-depleted mouse: a role in the treatment of Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Neurochemical and behavioural investigations of the NMDA receptor-associated glycine site in the rat striatum: functional implications for treatment of parkinsonian symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Topographical distribution of possible glutamatergic pathways from the frontal cortex to the striatum and substantia nigra in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Modulation of dopamine D1-mediated turning behavior and striatal c-fos expression by the substantia nigra.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Biochemical evidence for glutamate as neurotransmitter in corticostriatal and corticothalamic fibres in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Synergistic interactions between NMDA-antagonists and L-dopa on activity in MPTP-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

The neostriatal mosaic: multiple levels of compartmental organization

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Pharmacology of the corticocaudate excitatory postsynaptic potential in the cat: evidence for its mediation by quisqualate- or kainate-receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Motor effects of lamotrigine in naive and dopamine-depleted mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

The glycine site of the NMDA receptor--five years on.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Molecular diversity of the NMDA receptor channel

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

The receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

The AMPA receptor antagonist NBQX does not alter the motor response induced by selective dopamine agonists in MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Increases in extracellular dopamine levels and locomotor activity after direct infusion of phencyclidine into the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Basal ganglia intrinsic circuits and their role in behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Heteromeric NMDA receptors: molecular and functional distinction of subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Molecular cloning and characterization of the rat NMDA receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Molecular diversity of glutamate receptors and implications for brain function

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

The role of excitatory amino acids in experimental models of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Intraneostriatal administration of glutamate antagonists increases behavioral activation and decreases neostriatal ascorbate via nondopaminergic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Glutamate release in vitro from corticostriatal terminals

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Terminals of subthalamonigral fibres are enriched with glutamate-like immunoreactivity: An electron microscopic, immunogold analysis in the cat

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Intrastriatal injection of DL-2-amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Excitatory amino acids and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Contralateral disappearance of parkinsonian signs after subthalamic hematoma

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Centrally-administered glycine antagonists increase locomotion in monoamine-depleted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Antiparkinsonian actions of glutamate antagonists--alone and with L-DOPA: a review of evidence and suggestions for possible mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Facilitation of dopamine D1 receptor- but not dopamine D1/D2 receptor-dependent locomotion by glutamate antagonists in the reserpine-treated mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Glutamate antagonists modify the motor stimulant actions of D1 and D2 agonists in reserpine-treated mice in complex ways that are not predictive of their interactions with the mixed D1/D2 agonist apomorphine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Comparison of the effects of NMDA and AMPA antagonists on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Intranigral but not intrastriatal microinjection of the NMDA antagonist MK-801 induces contralateral circling in the 6-OHDA rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Injection of the competitive NMDA receptor antagonist AP-5 into the nucleus accumbens of monoamine-depleted mice induces pronounced locomotor stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

A morphological evidence for monosynaptic projections from the nucleus tegmenti pedunculopontinus pars compacta (TPC) to nigrostriatal projection neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

NBQX (6-nitro-sulfamoyl-benzo-quinoxaline-dione) and CPP (3-carboxy- piperazin-propyl phosphonic acid) potentiate dopamine agonist induced rotations in substantia nigra lesioned rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Modulation of the NMDA receptor by polyamines

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

The competitive NMDA antagonist CGP40.116 enhances L-dopa response in MPTP-treated marmosets

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

Distinct sites of dopaminergic and glutamatergic regulation of haloperidol-induced catalepsy within the rat caudate-putamen

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2896%2900407-1

7 January 2021

10.1016/S0306-4522(96)00407-1

Identifiers

DOI

1 reference

15 February 2018

1 reference

15 February 2018